NCT Number: NCT00355225
Community-Effectiveness of the Distribution of Insecticide-Treated Bed Nets Through Social Marketing Antenatal Care Services in Malaria Control in Rural Burkina Faso
The study aims at assessing which of two distribution channels for insecticide treated bendnets (ITNs), social marketing vs. social marketing coupled with free distribution through ante-natal care, is most effective in reaching groups at high risk of malaria, i.e. pregnant women and children under 5.
Looking for future studies?
Notify MeKey information
Conditions
Age range
0 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
The hypothesis that insecticide-treated bed net (ITN) effects may not be long-lasting in young children living in areas of intense malaria transmission due to interactions with the immunologi-cal development has now been refuted in a number of studies including the D4 study. The highly controversial question remains how African programmes can best reach a sustainable high coverage with ITNs in young children and pregnant women. Against this background it is planned to implement a cluster randomised controlled trial in Nouna Health District in Burkina Faso. Twenty-two peripheral health centres and their catchment areas will be randomised to (1) ITN provision to the general population through social marketing and (2) ITN provision to the general population through social marketing plus free provision to all pregnant women through antenatal services. The primary outcomes are ITN coverage in households and ITN use during pregnancy and infancy.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Being one of 25 primary health facility catchment areas in the Nouna Health District, Burkina Faso
Exclusion criteria
- Being outside one of 25 primary health facility catchment areas in the Nouna Health District, Burkina Faso
Treatment and study plan
Primary outcomes
-
ITN coverage in households 12 and 24 months after the start of the interventions
-
ITN use during pregnancy and infancy
Secondary outcomes
-
Costs per malaria case and per DALY prevented
-
Self-reported information on ANC visits
-
Insecticide content on ITN and mortality of vector mosquitoes over time
-
Acceptance of health staff and population
Sponsors and collaborators
Lead sponsor
Heidelberg University
Other
Registry information
Important dates
- First posted
- Jul 21, 2006
- Registry last updated
- Oct 9, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study to Assess the Safety and Effectiveness of Two Experimental Malaria Vaccines
NCT05978037
Infections, Malaria
Oxford, Oxfordshire, United Kingdom
View Trial DetailsSafety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
NCT05891236
Infections, Malaria
Baltimore, Maryland, United States
View Trial DetailsL9LS in Women of Childbearing Potential in Mali
NCT07060508
Infections, Malaria
Faladié, Koulikoro, Mali
View Trial DetailsStar Homes Project 2
NCT04529434
Diarrhoea;Acute, Infections
Dar Es Salaam, Mtwara, Tanzania
View Trial Details